Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update by Carolyn Helms | Aug 5, 2021 | Portfolio News
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline by Carolyn Helms | Aug 5, 2021 | Portfolio News
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors by Carolyn Helms | Aug 3, 2021 | Portfolio News
89bio Completed Target Enrollment in Histology Cohort to Evaluate BIO89-100 for the Treatment of NASH by Carolyn Helms | Aug 2, 2021 | Portfolio News
